Replacement Products and Replacement Fractionation Products. Any Replacement Products or Replacement Fractionation Products proposed by Bayer Canada under Sections 3.8, 3.9, 6.12, 7.2 and 7.3 must be licensed by Health Canada or if no Replacement Products or Replacement Fractionation Products are licensed by Health Canada, approved by Health Canada under its SAP.
Appears in 2 contracts
Samples: Purchase Agreement (Talecris Biotherapeutics Holdings Corp.), Purchase Agreement (Talecris Biotherapeutics Holdings Corp.)
Replacement Products and Replacement Fractionation Products. Any Replacement Products or Replacement Fractionation Products proposed by Bayer Canada Supplier under Sections 3.6, 3.8, 3.9, 6.128.12, 7.2 9.3 and 7.3 9.4 must be licensed by Health Canada or if no Replacement Products or Replacement Fractionation Products are licensed by Health Canada, approved by Health Canada under its SAP.
Appears in 2 contracts
Samples: Fractionation Services and Commercial Products Agreement (Talecris Biotherapeutics Holdings Corp.), Fractionation Services and Commercial Products Agreement (Talecris Biotherapeutics Holdings Corp.)
Replacement Products and Replacement Fractionation Products. Any Replacement Products or Replacement Fractionation Products proposed by Bayer Canada Supplier under Sections 3.6, 3.8, 3.9, 6.12, 7.2 7.3 and 7.3 7.4 must be licensed by Health Canada or if no Replacement Products or Replacement Fractionation Products are licensed by Health Canada, approved by Health Canada under its SAP.
Appears in 2 contracts
Samples: Contract Fractionation Services and Commercial Products Agreement (Talecris Biotherapeutics Holdings Corp.), Contract Fractionation Services and Commercial Products Agreement (Talecris Biotherapeutics Holdings Corp.)
